Fate Therapeutics, Inc.
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of …
Biotechnology
US, San Diego [HQ]
Earnings Call Transcripts
Earnings Call · Transcripts · SpeakersThis analysis tool shows transcript versions of the official earnings calls hosted by Fate Therapeutics, Inc.
Could not find a transcript
Peer Group
-
Sorry! None of FATE's peers has listed transcripts.
Upcoming Transcript Tools
- Full Text Search - Across All Transcripts
- Detail Speaker Profiles
- Non-US Transcripts